Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis

被引:0
|
作者
Liu, Zhiyao [1 ]
Huang, Hailiang [1 ]
Yu, Ying [2 ]
Jia, Yuqi [1 ]
Li, Lingling [1 ]
Shi, Xin [1 ]
Wang, Fangqi [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan 250355, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan 250355, Shandong, Peoples R China
关键词
Colchicine; coronavirus disease-19; non-small cell lung cancer; network pharmacology; bioinformatics analysis; molecular docking; molecular dynamics simulation; INTERLEUKIN-17; DISEASE; LESIONS; GENES; IL-17; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colchicine is an alkaloid with antitumor effect isolated from Colchicum autumnale plants, it has been reported in multiple studies as a potential treatment for coronavirus disease-19 and this study applied network pharmacology and bioinformatics analysis to explore the potential mechanism of colchicine against non-small cell lung cancer and coronavirus disease-19. The R software was used to determine the differentially expressed genes of non-small cell lung cancer/coronavirus disease-19, and carry out prognostic analysis and clinical analysis of the differentially expressed genes, the targets of colchicine were obtained from various databases, the protein-protein interaction network of intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 was constructed, enrichment analysis of gene ontology and kyoto encyclopedia of genes and genomes pathways was performed by Metascape database and the molecular docking and molecular dynamics simulation were completed. We obtained a total of 716 differentially expressed genes and identified 13 potential prognostic genes associated with the clinical characterization of non-small cell lung cancer/coronavirus disease-19 patients. C-C motif chemokine ligand 2, toll like receptor 4, intercellular adhesion molecule 1, peroxisome proliferator activated receptor gamma, interleukin 17A, interferon gamma, angiotensin I converting enzyme, fos proto-oncogene, nuclear factor kappa B inhibitor alpha, TIMP metallopeptidase inhibitor 1 and secreted phosphoprotein 1 were core targets. The intersection targets of colchicine and non-small cell lung cancer/coronavirus disease-19 were mainly enriched in biological processes such as inflammatory response, response to cytokine and response to lipopolysaccharide, as well as signal pathways such as interleukin 17 signaling pathway, hypoxia inducible factor 1 signaling pathway and nucleotide binding oligomerization domain-like receptor signaling pathway. The results of molecular docking showed that the colchicine is better combined with the core targets. Analysis of molecular dynamics simulation showed that the protein and ligand form a stabilizing effect. Based on bioinformatics analysis and network pharmacology, we obtained biomarkers that may be used for the prognosis of non-small cell lung cancer/coronavirus disease-19 patients and revealed that colchicine may play a potential role in the treatment of non-small cell lung cancer/coronavirus disease-19 by regulating multiple targets and multiple signaling pathways and participating in multiple biological processes.
引用
收藏
页码:199 / 216
页数:18
相关论文
共 50 条
  • [41] Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19
    Yaojun Wang
    Ming Ding
    Jiaoni Chi
    Tao Wang
    Yue Zhang
    Zhimin Li
    Qiang Li
    Scientific Reports, 13
  • [42] Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19
    Wang, Yaojun
    Ding, Ming
    Chi, Jiaoni
    Wang, Tao
    Zhang, Yue
    Li, Zhimin
    Li, Qiang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology
    Liu, Zhiyao
    Huang, Hailiang
    Yu, Ying
    Li, Lingling
    Shi, Xin
    Wang, Fangqi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (23) : 3878 - 3896
  • [44] Multitarget and Multipathway Regulation of Zhenqi Fuzheng Granule against Non-Small Cell Lung Cancer Based On Network Pharmacology and Molecular Docking
    Zhou, Yanqing
    Wu, Chenxi
    Qian, Xian
    Zhou, Jin
    Li, Chengjian
    Jiao, Yang
    Li, Yue Yue
    Zhao, Liang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [45] Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis
    Gao, Peng
    Ren, Guanghui
    AGING-US, 2021, 13 (19): : 23245 - 23261
  • [46] Screening of potential biomarkers and their predictive value in early stage non-small cell lung cancer: a bioinformatics analysis
    Tu, Hongbin
    Wu, Meihong
    Huang, Weiling
    Wang, Lixin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 797 - 807
  • [47] Comprehensive analysis of the potential mechanism of gansui in blocking non-small cell lung cancer progression
    Yang, Xiaoxu
    Li, Wenlan
    PHARMACEUTICAL BIOLOGY, 2025, 63 (01) : 170 - 187
  • [48] Evaluating treatment strategies for non-small cell lung cancer during COVID-19: A propensity score matching analysis
    Yu, Minhao
    Cheng, Yalin
    Zhang, Renfei
    Wen, Tao
    Huai, Sitao
    Wei, Xiubo
    Zhang, Liming
    MEDICINE, 2022, 101 (32) : E30051
  • [49] The Effect of COVID-19 On Treatment Outcomes in Non-Small Cell Lung Cancer Patients: A Propensity Score Matched Analysis
    Aung, W. Y.
    Sood, A.
    Hou, L.
    Elengickal, J.
    Peketi, S. H.
    Locke, M.
    Zhou, X.
    Sangari, A.
    Seetharamu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S403 - S404
  • [50] Paper The Mechanism of Wenhua Decoction in the Treatment of Non-Small Cell Lung Cancer by Network Pharmacology and Molecular Dynamics Simulation
    Wei, D.
    JOURNAL OF HERBAL MEDICINE, 2024, 48